Apellis Down on Negative CHMP Opinion for Pegcetacoplan - Nasdaq

DERM Stock  USD 5.55  0.19  3.31%   
About 65% of Journey Medical's investor base is looking to short. The analysis of the overall investor sentiment regarding Journey Medical Corp suggests that many traders are alarmed. Journey Medical's investing sentiment overview a quick insight into current market opportunities from investing in Journey Medical Corp. Many technical investors use Journey Medical Corp stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Apellis Down on Negative CHMP Opinion for Pegcetacoplan Nasdaq

Read at news.google.com
Google News at Macroaxis
  

Journey Medical Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Journey Medical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Journey Medical Fundamental Analysis

We analyze Journey Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Journey Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Journey Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Probability Of Bankruptcy

Probability Of Bankruptcy Comparative Analysis

Journey Medical is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Journey Medical Corp Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Journey Medical stock to make a market-neutral strategy. Peer analysis of Journey Medical could also be used in its relative valuation, which is a method of valuing Journey Medical by comparing valuation metrics with similar companies.

Peers

Journey Medical Related Equities

AQSTAquestive Therapeutics   5.74   
0%
100.0%
TCNNFTrulieve Cannabis   3.55   
0%
61.0%
ACBAurora Cannabis   2.95   
0%
51.0%
CRLBFCresco Labs   2.48   
0%
43.0%
CURLFCuraleaf Holdings   1.51   
0%
26.0%
LFCRLifecore Biomedical   0.81   
0%
14.0%
AVDLAvadel Pharmaceuticals   0.18   
0%
3.0%
EVOKEvoke Pharma   0.46   
8.0%
0%
ORGOOrganogenesis Holdings   1.52   
26.0%
0%
SHPHShuttle Pharmaceuticals   2.30   
40.0%
0%
When determining whether Journey Medical Corp is a strong investment it is important to analyze Journey Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Journey Medical's future performance. For an informed investment choice regarding Journey Stock, refer to the following important reports:
Check out Journey Medical Hype Analysis, Journey Medical Correlation and Journey Medical Performance.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Journey Medical. If investors know Journey will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Journey Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.92)
Revenue Per Share
2.921
Quarterly Revenue Growth
(0.58)
Return On Assets
(0.17)
Return On Equity
(1.30)
The market value of Journey Medical Corp is measured differently than its book value, which is the value of Journey that is recorded on the company's balance sheet. Investors also form their own opinion of Journey Medical's value that differs from its market value or its book value, called intrinsic value, which is Journey Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Journey Medical's market value can be influenced by many factors that don't directly affect Journey Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Journey Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Journey Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Journey Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.